Shenzhen Leibang Glasses Co., Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Leibang Glasses Co., Ltd. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 2 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include MGEHKAI and GENTLE MGHKA. The owner is based in Longgang, Shenzhen.

Silian Maosheng, Henggang Street,

4/F, Building A, No.1 Liansheng Lane,

Longgang, Shenzhen 518000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Shenzhen Leibang Glasses Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Shenzhen Leibang Glasses Co., Ltd. have?

Shenzhen Leibang Glasses Co., Ltd. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Shenzhen Leibang Glasses Co., Ltd. file in?

Shenzhen Leibang Glasses Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Shenzhen Leibang Glasses Co., Ltd.'s most well-known trademarks?

Shenzhen Leibang Glasses Co., Ltd.'s registered trademark portfolio includes well-known marks such as MGEHKAI and GENTLE MGHKA. These are among 2 currently registered trademarks in the portfolio.

What is Shenzhen Leibang Glasses Co., Ltd.'s trademark registration success rate?

Shenzhen Leibang Glasses Co., Ltd. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.